Most sold healthcare stocks in Q3 2026
Discover which Healthcare stocks institutional investors trimmed or exited the most over Q3 2026 versus the prior calendar quarter in our filings. Notable reductions at the top of this list include PFIZER INC (PFE), MERCK & CO. INC. (MRK), JOHNSON & JOHNSON (JNJ), BRISTOL-MYERS SQUIBB CO (BMY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share decreases
Top symbols by net quarter-over-quarter share change (decreases).
Most sold stocks
Net quarter-over-quarter share reductions across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| PFE | PFIZER INC | -3,690,637,434 | -$89.3B | 0 | 3 | 4 | 2726 | 9 |
| MRK | MERCK & CO. INC. | -1,906,851,323 | -$245.3B | 0 | 3 | 6 | 3696 | 11 |
| JNJ | JOHNSON & JOHNSON | -1,726,571,847 | -$439.8B | 0 | 3 | 4 | 4507 | 12 |
| BMY | BRISTOL-MYERS SQUIBB CO | -1,629,018,173 | -$101.8B | 0 | 4 | 3 | 2421 | 10 |
| ABT | ABBOTT LABORATORIES | -1,320,653,958 | -$120.0B | 0 | 4 | 4 | 2866 | 8 |
| ABBV | ABBVIE INC | -1,273,267,774 | -$342.3B | 0 | 4 | 5 | 4070 | 11 |
| BSX | BOSTON SCIENTIFIC CORP | -1,262,398,847 | -$57.3B | 0 | 0 | 1 | 1427 | 2 |
| CVS | CVS HEALTH CORP | -1,102,500,044 | -$115.0B | 0 | 0 | 3 | 1998 | 5 |
| GILD | GILEAD SCIENCES INC | -1,073,889,078 | -$136.7B | 1 | 4 | 2 | 2187 | 11 |
| VTRS | VIATRIS INC | -1,027,091,492 | -$16.3B | 0 | 0 | 0 | 982 | 0 |
| LLY | ELI LILLY & CO | -762,443,810 | -$914.0B | 0 | 5 | 3 | 4468 | 10 |
| UNH | UNITEDHEALTH GROUP INC | -756,008,874 | -$313.0B | 1 | 0 | 3 | 3271 | 6 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -719,807,201 | -$24.3B | 0 | 0 | 0 | 647 | 1 |
| AVTR | AVANTOR INC | -695,294,205 | -$6.9B | 0 | 0 | 0 | 438 | 0 |
| HLN | HALEON PLC-ADR | -587,574,941 | -$5.5B | 0 | 0 | 0 | 618 | 0 |
| ELAN | ELANCO ANIMAL HEALTH INC | -563,485,893 | -$13.9B | 0 | 0 | 0 | 497 | 0 |
| DHR | DANAHER CORP | -555,866,652 | -$110.2B | 1 | 0 | 3 | 2044 | 6 |
| BAX | BAXTER INTERNATIONAL INC | -553,317,215 | -$11.8B | 0 | 0 | 0 | 653 | 1 |
| ROIV | ROIVANT SCIENCES LTD | -551,956,231 | -$19.5B | 0 | 0 | 0 | 477 | 0 |
| EW | EDWARDS LIFESCIENCES CORP | -508,926,779 | -$45.9B | 0 | 0 | 1 | 1279 | 2 |
| GERN | GERON CORP | -474,155,308 | -$607.2M | 0 | 0 | 0 | 248 | 0 |
| CNC | CENTENE CORP | -470,441,688 | -$31.0B | 0 | 0 | 0 | 966 | 1 |
| AMGN | AMGEN INC | -431,770,666 | -$156.1B | 0 | 3 | 2 | 3042 | 8 |
| GEHC | GE HEALTHCARE TECHNOLOGY | -387,372,946 | -$24.8B | 0 | 1 | 0 | 1171 | 3 |
| ZTS | ZOETIS INC | -382,194,534 | -$27.5B | 0 | 1 | 0 | 1374 | 2 |
| GOSS | GOSSAMER BIO INC | -370,238,674 | -$60.8M | 0 | 0 | 0 | 165 | 0 |
| LFST | LIFESTANCE HEALTH GROUP INC | -368,426,535 | -$3.9B | 0 | 0 | 0 | 276 | 0 |
| LXRX | LEXICON PHARMACEUTICALS INC | -364,586,946 | -$875.0M | 0 | 0 | 0 | 144 | 0 |
| DXCM | DEXCOM INC | -362,645,162 | -$26.9B | 1 | 0 | 0 | 940 | 2 |
| RXRX | RECURSION PHARMACEUTICALS-A | -360,399,783 | -$1.3B | 1 | 0 | 0 | 326 | 1 |
| GSK | GSK PLC-SPON ADR | -343,247,725 | -$18.0B | 0 | 1 | 0 | 999 | 2 |
| TMO | THERMO FISHER SCIENTIFIC INC | -321,863,266 | -$162.1B | 1 | 0 | 5 | 2526 | 8 |
| MRNA | MODERNA INC | -315,630,185 | -$22.1B | 2 | 0 | 0 | 746 | 2 |
| ALLO | ALLOGENE THERAPEUTICS INC | -312,222,972 | -$651.1M | 0 | 0 | 0 | 204 | 0 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -310,935,643 | -$15.5B | 0 | 1 | 2 | 1299 | 4 |
| TSHA | TAYSHA GENE THERAPIES INC | -299,064,648 | -$2.1B | 0 | 0 | 0 | 203 | 0 |
| SYK | STRYKER CORP | -296,206,681 | -$93.5B | 0 | 1 | 6 | 2174 | 9 |
| LAB | STANDARD BIOTOOLS INC | -295,648,119 | -$243.2M | 0 | 0 | 0 | 138 | 0 |
| ISRG | INTUITIVE SURGICAL INC | -293,886,801 | -$117.1B | 0 | 1 | 3 | 2160 | 7 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | -285,147,049 | -$1.2B | 0 | 0 | 0 | 276 | 0 |
| SHC | SOTERA HEALTH CO | -283,439,425 | -$5.0B | 0 | 0 | 0 | 301 | 0 |
| ERAS | ERASCA INC | -279,352,587 | -$5.1B | 0 | 0 | 0 | 242 | 0 |
| BKD | BROOKDALE SENIOR LIVING INC | -265,459,944 | -$4.3B | 0 | 0 | 0 | 276 | 0 |
| A | AGILENT TECHNOLOGIES INC | -255,427,442 | -$34.5B | 0 | 0 | 0 | 1091 | 1 |
| EXEL | EXELIXIS INC | -254,502,833 | -$13.8B | 0 | 0 | 0 | 726 | 1 |
| BDX | BECTON DICKINSON AND CO | -251,426,184 | -$39.2B | 0 | 0 | 2 | 1377 | 4 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | -250,700,687 | -$2.5B | 0 | 0 | 1 | 302 | 1 |
| RLAY | RELAY THERAPEUTICS INC | -243,353,676 | -$4.5B | 0 | 0 | 0 | 245 | 0 |
| BHC | BAUSCH HEALTH COS INC | -236,781,160 | -$1.2B | 1 | 0 | 0 | 209 | 1 |
| NEOG | NEOGEN CORP | -236,434,087 | -$2.1B | 0 | 0 | 0 | 298 | 0 |